60 completed, 28 recruiting, 26 unknown, 14 active not recruiting. 58 Phase 2, 27 Phase 1, 24 Not applicable, 7 Phase 3, 4 Early Phase 1.
Follow Adenoma, Islet Cell: new trials by email Literature Review of Adenoma, Islet Cell trials Research Report on Adenoma, Islet Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms Clinical Intervention or Procedure, Electronic Health Record Review, Endoscopic Ultrasound-Guided Fine-Needle Aspiration of the Pancreas - Pancreatic Neoplasm, Pancreatic Neuroendocrine Tumor | Not applicable | Enrolling by invitation | Ohio State University Comprehensive Cancer Center | 12 | 2027-10-01 | 2026-10-13 |
| Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas Biospecimen Collection, Computed Tomography, Incomplete Freund''s Adjuvant - Digestive System Neuroendocrine Neoplasm, Lung Neuroendocrine Neoplasm | Phase 2 | Not yet recruiting | Roswell Park Cancer Institute | 60 | 2026-12-15 | 2026-10-20 |
| Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma Localization [68Ga]Ga-HBED-CC-PEG6-exendin-4 PET/CT, [68Ga]Ga-HBED-CC-exendin-4 PET/CT - Insulinoma | Not applicable | Recruiting | Peking Union Medical College Hospital | 20 | 2026-10-01 | 2026-09-09 |
| Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical Evaluation cfDNA molecular profiling - Pancreatic Neuroendocrine Tumor | Active not recruiting | Massimo Falconi | 30 | 2026-09-12 | 2026-09-16 | |
| Nutrition Intervention for Pancreatic Cancer Structured Lipid Medical Food - Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Neuroendocrine Tumor (NET) | Not applicable | Recruiting | Children's Hospital of Philadelphia | 18 | 2026-04-07 | 2026-05-07 |
| AI-Powered Precision Decision-Making for Pancreatic Diseases Diagnosis by Artificial Intelligence model - Pancreatic Cancer, Diagnose Disease | Recruiting | Changhai Hospital | 2000 | 2026-03-01 | 2026-02-27 | |
| Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy Open Pancreaticoduodenectomy, Laparoscopic Pancreaticoduodenectomy - Pancreatic Ductal Adenocarcinoma, Ampullary Carcinoma | Not applicable | Recruiting | Minia University | 90 | 2026-01-17 | 2026-01-21 |
| Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not Debulking surgery - Pancreatic Neuroendocrine Tumor | Not applicable | Recruiting | Uppsala University | 200 | 2026-01-09 | 2026-01-22 |
| Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. RYZ401 - GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor | Phase 1 | Recruiting | RayzeBio, Inc. | 104 | 2025-12-03 | 2026-09-15 |
| Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions observational study - Insulinoma; Pancreas, MEN1 | Recruiting | Herlev Hospital | 138 | 2025-11-01 | 2025-12-09 | |
| Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors Biopsy, Biospecimen Collection, Computed Tomography - Metastatic Malignant Solid Neoplasm, Metastatic Melanoma | Phase 1 | Recruiting | Anusha Kalbasi | 18 | 2025-10-07 | 2026-03-17 |
| Patients With High-grade Pancreatic Neuroendocrine Tumors Lurbinectedin 4 MG Injection [Zepzelca] - Neuroendocrine Tumor of Pancreas, Pancreatic Neuroendocrine Tumors | Phase 2 | Enrolling by invitation | National Cancer Center, Korea | 46 | 2025-09-23 | 2025-10-01 |
| Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors Zanzalintinib, Everolimus - Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET) | Phase 2 / Phase 3 | Recruiting | Exelixis | 440 | 2025-07-21 | 2026-09-29 |
| A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism Ersodetug - Tumor Hyperinsulinism (Tumor HI) | Phase 3 | Recruiting | Rezolute | 16 | 2025-04-16 | 2026-09-28 |
| Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma EUS-RFA - Insulinoma; Pancreas | Recruiting | Sahlgrenska University Hospital | 20 | 2025-03-31 | 2026-05-13 | |
| Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors Fulvestrant, 177Lu-DOTATATE - Metastatic Pancreatic Neuroendocrine Tumor | Phase 1 | Recruiting | University of Chicago | 25 | 2024-12-13 | 2026-01-09 |
| A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET sorafenib, gefitinib - Pancreatic Neuroendocrine Neoplasm, Sorafenib | Unknown | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 20 | 2024-09-30 | 2025-01-10 | |
| Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors Biospecimen Collection, Computed Tomography, Lutetium Lu 177 Dotatate - Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Neoplasm | Phase 1 | Recruiting | National Cancer Institute (NCI) | 24 | 2024-08-14 | 2026-10-20 |
| A Study of Surufatinib as Adjuvant Therapy for Pancreatic Neuroendocrine Tumors Surufatinib, Placebo - Pancreatic Neuroendocrine Tumor | Phase 2 | Terminated | Changhai Hospital | 6 | 2024-06-17 | 2026-06-11 |
| ATRX/DAXX in EUS-FNB Specimens of Pan-NETs ATRX/DAXX immunohistochemistry - Pancreatic Neuroendocrine Tumor | Active not recruiting | Azienda Ospedaliera Universitaria Integrata Verona | 100 | 2024-06-01 | 2026-01-13 |
Showing 20 of 158. Sign in to see all of them.
Insulinoma (62) · Somatostatinoma (35) · Glucagonoma (33) · Neuroendocrine Tumors (33) · Gastrinoma (31) · Carcinoma, Islet Cell (29) · Pancreatic Neoplasms (27) · Vipoma (20) · Carcinoid Tumor (19) · Neoplasms (19) · Pheochromocytoma (13) · Carcinoma, Medullary (12) · Carcinoma, Renal Cell (11) · Neoplasm Metastasis (10)
Adenoma (157) · Digestive System Diseases (157) · Endocrine System Diseases (157) · Digestive System Neoplasms (156) · Endocrine Gland Neoplasms (156) · Neoplasms by Histologic Type (156) · Neoplasms by Site (156) · Neoplasms, Glandular and Epithelial (156) · Pancreatic Diseases (153) · Neoplasms (139) · Pancreatic Neoplasms (131) · Neoplasms, Germ Cell and Embryonal (77) · Neuroectodermal Tumors (77) · Adenocarcinoma (67) · Carcinoma (67)
Everolimus (13) · Temozolomide (9) · Sunitinib (7) · Capecitabine (6) · Octreotide (6) · Fluorouracil (4) · Leucovorin (4) · Magnetic Resonance Spectroscopy (4) · Specimen Handling (4) · fluorodopa F 18 (4) · Bevacizumab (3) · Injections (3) · Oxaliplatin (3) · Sorafenib (3) · lutetium Lu 177 dotatate (3)
National Cancer Institute (NCI) (11) · Peking Union Medical College Hospital (7) · Dana-Farber Cancer Institute (5) · Fudan University (5) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (5) · British Columbia Cancer Agency (3) · Guangxi Medical University (3) · Vanderbilt-Ingram Cancer Center (3) · Azienda Ospedaliera Universitaria Integrata Verona (2) · Changhai Hospital (2) · Children's Hospital of Philadelphia (2) · ECOG-ACRIN Cancer Research Group (2) · Eastern Cooperative Oncology Group (2) · European Institute of Oncology (2) · H. Lee Moffitt Cancer Center and Research Institute (2)
United States (80) · China (30) · France (12) · Italy (12) · Canada (10) · Netherlands (10) · United Kingdom (8) · Spain (7) · Sweden (6) · Belgium (5) · Brazil (5) · Germany (5) · South Korea (5) · Australia (4) · Denmark (4)
Xianjun Yu, MD, PhD (4) · Francois Benard, MD (2) · James Yao (2) · Jasmeet Kaur, MD (2) · Jennifer Chan, MD, MPH (2) · Leonard B. Saltz, MD (2) · Mary Mulcahy, MD (2) · Timothy Hobday (2) · Xiaowu Xu, MD (2) · Ye Yuan, MD (2) · Aiming Yang, M.D. (1) · Allison Betof Warner, MD, PhD (1) · Ana Maria Arbelaez, MD, MSCI (1)
PMID 14673042, PMID 16924083, PMID 17438169, PMID 18703486, PMID 19704057, PMID 19820010, PMID 20847174, PMID 21831734, PMID 22480131, PMID 22722717, PMID 22736724, PMID 23475104, PMID 23516312, PMID 25325684, PMID 25688512, PMID 25689042, PMID 25900182, PMID 25956795, PMID 26158612, PMID 26703889, PMID 26769865, PMID 27020837, PMID 27050056, PMID 27576181, PMID 29853660, PMID 30138162, PMID 30347425, PMID 30833272, PMID 31410626, PMID 31555796, PMID 32384122, PMID 33152282, PMID 33523367, PMID 33788183, PMID 34012671, PMID 34388377, PMID 35348774, PMID 35389428, PMID 35419649, PMID 36140756, PMID 36188432, PMID 36260828, PMID 36470974, PMID 36891979, PMID 37671264, PMID 37774329, PMID 38569703, PMID 38610840, PMID 38652200, PMID 38753757
P30CA016672 (3), N01CM62205 (2), U01CA062461 (2), U01CA076576 (2), U10CA021115 (2), U10CA180821 (2), 2014 (1), 2023 (1), 2025 (1), N01CM62202 (1), P30CA014089 (1), P30CA015704 (1), P50CA102701 (1), R01CA243014 (1), R44CA203052 (1)